Combined Effects of Inflammation and Aging in Premature Ovarian Insufficiency: Unraveling Mechanisms and Advancing Therapeutic Strategies
Clinical and Experimental Obstetrics & Gynecology · 09.07.2026 · 53 (7)
DOI: 10.31083/ceog48282 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Obstetrics & Gynecology, online erschienen am 09.07.2026. Verfasst von Tao Cao und 4 weiteren Autor:innen. Die Arbeit nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives:Premature ovarian insufficiency (POI) affects approximately 3.5% of women worldwide, and its pathogenesis is increasingly associated with the interplay of genetic, autoimmune, and environmental factors. This review aims to: (1) examine the synergistic effects of chronic inflammation and biological aging in accelerating ovarian reserve depletion; (2) evaluate the efficacy and limitations of current management strategies; and (3) explore the potential of emerging regenerative therapies, with an emphasis on integrating precision medicine frameworks in POI care.Mechanism:A systematic literature search was conducted across PubMed, Web of Science, and ClinicalTrials.gov from database inception to December 3, 2024. Search terms included combinations of “premature ovarian insufficiency”, “primary ovarian insufficiency”, “ovarian aging”, “inflammation”, “senescence”, “therapy”, and “regenerative medicine”. The review encompassed preclinical studies, clinical trials, and meta-analyses. Publications were screened by title, abstract, and full text for relevance, with a focus on human studies and high-impact translational research that elucidates pathogenic mechanisms or therapeutic innovations.Findings in Brief:The pathogenesis of POI is critically driven by a self-reinforcing cycle wherein chronic inflammation, mediated via nuclear factor kappa B (NF-κB) and Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathways, interacts with cellular aging to amplify oxidative stress and follicular apoptosis. This process is further exacerbated by senescence-associated secretory phenotypes (SASPs). Current standard of care, such as hormone replacement therapy (HRT), effectively manages symptoms but shows limited efficacy in restoring ovarian function or fertility. Antioxidant therapies have yielded inconsistent outcomes. Emerging regenerative strategies, including stem cell therapies, exosomal microRNA (miRNA) delivery, and platelet-rich plasma (PRP) applications, demonstrate potential for ovarian rejuvenation in preclinical and early clinical studies, yet require further validation.Conclusions:Advancing POI management requires a shift beyond symptomatic relief toward targeting the underlying inflammation aging axis. Integrating multimodal therapies with biomarker-guided precision medicine represents a feasible strategy to disrupt the self-perpetuating disease cycle. Future research should prioritize robust clinical trials to validate regenerative approaches and establish patient-specific therapeutic algorithms, aiming not only to alleviate symptoms but also to preserve or restore ovarian function.
Zitieren
APA
Cao, T., Lin, X., Li, X., Zhang, Q., & Zhao, D. (2026). Combined Effects of Inflammation and Aging in Premature Ovarian Insufficiency: Unraveling Mechanisms and Advancing Therapeutic Strategies. Clinical and Experimental Obstetrics & Gynecology, 53(7). https://doi.org/10.31083/ceog48282
Vancouver
Cao T, Lin X, Li X, Zhang Q, Zhao D. Combined Effects of Inflammation and Aging in Premature Ovarian Insufficiency: Unraveling Mechanisms and Advancing Therapeutic Strategies. Clinical and Experimental Obstetrics & Gynecology. 2026;53(7). doi:10.31083/ceog48282
BibTeX
@article{Cao2026,
author = {Cao, Tao and Lin, Xianhua and Li, Xuemei and Zhang, Qingqing and Zhao, Depeng},
title = {Combined Effects of Inflammation and Aging in Premature Ovarian Insufficiency: Unraveling Mechanisms and Advancing Therapeutic Strategies},
journal = {Clinical and Experimental Obstetrics & Gynecology},
year = {2026},
volume = {53},
number = {7},
doi = {10.31083/ceog48282}
}
EUVIMED